China's Robot Supply Chain Arrives on SGX: a Real Industry, but look past the Humanoid Hype

The iFAST ChinaAMC CSI Robot Index ETF (SGX: RBZ) is coming to SGX, giving Singapore investors an SGD-traded way to access China's robotics supply chain. The access is new, but so is much of the commercial case for humanoid robots.

Tan Qiuyi Charmaine
Tan Qiuyi Charmaine11 Nov 2026 3 Views
China's Robot Supply Chain Arrives on SGX: a Real Industry, but look past the Humanoid Hype

  • Why robotics: China installed 354,000 industrial robots in 2025, or 59% of the global total, making factory automation an established market rather than only a future theme.
  • Humanoids remain unproven: China's National Development and Reform Commission has warned of bubble risk, while entry-level prices have fallen quickly and shipment volumes remain small.
  • More than pure robot makers: The CSI Robot Index is weighted towards component and automation suppliers, many of which also depend on the auto, electronics and capex cycles.
  • Expect volatility: The index gained 30.8% in 2025 but fell 22.2% in 3Q26, leaving it down 12.2% year to date (in CNY terms).
  • Accessible through SGX: The ETF is traded in SGD, with a minimum subscription of one share, an offer price of SGD 1 and an expected overall total expense ratio of 0.64% p.a. The Initial Offer Period runs from 10 to 27 November 2026, with listing targeted for 7 December 2026.

Robotics has become one of the most closely watched themes in China's equity market. The CSI Robot Index gained 30.8% in 2025 (in CNY terms), and China's latest Five-Year Plan points its AI research towards physical uses, with robots as a main driver of growth.

The past few months have been a reminder of how quickly such a theme can reverse. The index fell 22.2% in 3Q26, leaving it down 12.2% year-to-date as of 30 September 2026 (in CNY terms). The question for investors is not whether robots will be used more widely, but how much of that future is worth paying for today.

China's robot industry has real scale, but humanoids are still unproven

Industrial robots are the established part of the story

China's position in factory automation rests on real deployment. The International Federation of Robotics (IFR) counted 603,000 new industrial robots installed globally in 2025. China installed 354,000 of them, or 59% of the total, with its number of installations up 20% from 2024.

That said, recent growth should not simply be extrapolated. The IFR forecasts global installations of 655,000 units in 2026 and 806,000 by 2029, implying about 7% annual growth from 2026, well below China’s 20% in 2025.

Within China, installations by domestic suppliers grew 15% YoY in 2025, reaching 55% of total installations (2024: 57%). Competition remains intense, with installations by foreign suppliers up 27% YoY over the same period.

Humanoids drive sentiment, but the commercial evidence is thinner

Much of the recent investor interest has centred on humanoid robots. In November 2025, the National Development and Reform Commission cautioned that the sector was not yet mature in technology, commercialisation or use, and flagged bubble risk among more than 150 humanoid makers.

Price competition has since become more visible. Entry-level models have been launched below RMB 10,000, and Caixin has reported signs of EV-style price wars. Volumes also remain small, with UBS projecting global humanoid shipments of about 30,000 units in 2026, up from nearly 13,000 in 2025.

This matters for the CSI Robot Index as it holds mainly component and automation suppliers rather than humanoid makers. Suppliers do not need to back the winning robot maker, but price wars among humanoid makers are likely to put pressure on what they can charge for parts such as actuators and reducers. With shipments still small, humanoid demand is also unlikely to be a major driver of these suppliers’ earnings in the near term. Investors should separate the growth of the technology from the returns that shareholders may ultimately earn from it.

Related article: Digital Economy Series: Robotics & Humanoids – AI’s upcoming playing field

Related article: Q&A Series: Humanoid robots could be AI’s next big wave

Bringing China's robot supply chain to SGX

For Singapore investors, accessing China's robotics companies has typically required investing through overseas markets. Many of these companies are listed on the mainland A-share market, while China robotics ETFs such as those in Table 4 are listed outside of Singapore and trade in foreign currencies.

iFAST, in partnership with China Asset Management (ChinaAMC), is introducing the iFAST ChinaAMC CSI Robot Index ETF (SGX: RBZ). ChinaAMC had USD 463 billion in assets under management as of 30 June 2026, including subsidiaries. The ETF aims to track the CSI Robot Index, before fees and expenses, by investing in the Shanghai-listed ChinaAMC CSI Robot ETF (SSE: 562500), which was launched in December 2021, under the SSE-SGX ETF Connect. The underlying ETF’s average daily tracking difference and annual tracking error were 0.0001% and 0.31% respectively from 1 August 2025 to 31 July 2026.

Investors can subscribe to the ETF during its Initial Offer Period (IOP) from 10 November to 27 November 2026 via iFAST. The IOP closes at 12:00pm on 27 November.

Table 1: iFAST ChinaAMC CSI Robot Index ETF: IOP details

ETF Details

ETF Name

iFAST ChinaAMC CSI Robot Index ETF

Reference Benchmark

CSI Robot Index

Underlying ETF

ChinaAMC CSI Robot ETF (SSE: 562500)

Issue Price

SGD 1 per share

Initial Offer Period (IOP)

10 Nov to 27 Nov 2026

Target Listing Date

7 Dec 2026

Base Currency

SGD

Trading Currency

SGD

SGX Code

RBZ

Minimum Subscription

1 Share

Trading Board Lot Size

1 Share

Management Fee

0.20% p.a.

Expected Overall Total Expense Ratio

0.64% p.a.

Distribution Policy

Nil

Classification Status

Excluded Investment Product

Subscription Mode

Cash is eligible during the IOP, while SRS eligibility will commence on listing day.

Source: iFAST Compilations. Overall TER comprises the Underlying Fund's TER and iFAST fees (management fee and fixed costs). Data as of 30 September 2026.

How the CSI Robot Index selects its constituents

The CSI Robot Index aims to reflect the performance of listed companies involved in robotics. Starting from the CSI All Share Index universe, it removes the bottom 20% of securities by average daily trading value over the past year.

From the remaining securities, it selects companies supplying software or hardware for robot production, including system solution providers, production-line integrators, automation equipment makers and component suppliers. Up to 100 companies are then chosen by average daily total market value over the past year, with weights based on free-float adjusted market capitalisation and individual weights capped at 10%. The index is rebalanced semi-annually in June and December and had 64 constituents as of 30 September 2026.

The June 2026 rebalance added core hardware suppliers such as Sanhua Intelligent Controls and Hengli Hydraulic and removed some downstream system integrators. This tilted the index towards humanoid component suppliers. Within three months, Sanhua (8.8%) and Hengli (5.3%) ranked among the six largest constituents, together making up 14.1% of the index as of 30 September 2026. Following the rebalance, Chinese media reported that the index’s humanoid robot content had risen to above 70%, which also makes the index more sensitive to shifts in humanoid sentiment.

To be clear, several of the largest constituents have sizeable established businesses outside robots, including auto parts, thermal management, laser equipment, speech AI and video surveillance. Investors are therefore buying a broader industrial and technology basket with robotics optionality, rather than a pure play on robot sales.

This can provide some diversification, but it also means earnings may depend on the auto, electronics and capex cycles. Machinery makes up 55.8% of the index, followed by computers at 14.9% and household appliances at 12.8%. The index is also concentrated, with the top 10 constituents accounting for 58.3%.

Table 2: Top 10 constituents of the CSI Robot Index

Company

Weight

Shenzhen Inovance Technology

9.1%

Sanhua Intelligent Controls

8.8%

iFLYTEK

7.9%

Han's Laser Technology

7.3%

Supcon Technology

5.6%

Hengli Hydraulic

5.3%

Ningbo Tuopu Group

4.5%

Leaderdrive

3.9%

Zhejiang Dahua Technology

3.3%

Zhejiang Shuanghuan Driveline

2.9%

Total

58.3%

Source: ChinaAMC, iFAST Compilations. Data as of 30 September 2026.

Total may not sum due to rounding.


Figure 1: Sector breakdown of the CSI Robot Index

Unitree's supply chain shows both the link and its limits

Unitree, the world's largest humanoid maker by volume, illustrates how the index connects to humanoid robots. Six of its major suppliers are index constituents and together make up about 23% of the index: Shenzhen Inovance Technology (motors and drives, 9.1%), Ningbo Tuopu Group (linear actuators, 4.5%), Leaderdrive (harmonic reducers, 3.9%), Zhejiang Shuanghuan Driveline (RV reducers, 2.9%), Orbbec (3D vision sensors, below 2%) and Zhongda Leader (planetary and harmonic reducers, below 1%).

However, being a supplier does not show how much of a company's revenue comes from humanoids. Zhongda Leader accounts for more than 63% of Unitree's reducer demand and has a supply agreement running from 2025 to 2027, yet it carries one of the smallest weights among the six. As the index is weighted by free-float market capitalisation, smaller companies receive smaller weights regardless of how closely they are tied to humanoids. This means much of the index's exposure sits with larger companies whose earnings also depend on other end markets.

Performance has been volatile, and valuations remain demanding

The index's record shows why position sizing matters. In CNY terms, it fell 31.8% in 2022, posted modest gains of 6.0% in 2023 and 4.3% in 2024, then rose 30.8% in 2025. Despite the strong 2025, it returned -0.8% annualised over the five years to 30 September 2026, with annualised volatility of roughly 30% to 33%.

Sharp moves can also happen when sentiment seems favourable. The index fell more than 7% intraday on 19 August 2026, as the World Robot Conference opened. At the end of September, the underlying ETF's price of CNY 0.897 stood about 27% below its 52-week high of CNY 1.233.

Table 3: China robotics ETFs have posted negative returns over the past year

ETF

3M

1Y

3Y p.a.

5Y p.a.

ChinaAMC CSI Robot ETF (SSE: 562500)

-22.0%

-18.0%

4.6%

-*

E Fund CNI Robot Industry Index ETF (SZSE: 159530)

-21.4%

-25.2%

-^

-^

Global X China Robotics and AI ETF (HKEX: 2807)

-24.9%

-28.2%

-0.5%

-3.5%

Annualised for periods over one year. Total returns in CNY terms.

*5Y data is not available for the ChinaAMC CSI Robot ETF, which launched in December 2021.

^3Y and 5Y data is not available for the E Fund CNI Robot Industry Index ETF (SZSE: 159530), which launched in January 2024.

Defiance China Robotics ETF (NASDAQ: CROB) is excluded as it launched on 18 Aug 2026.

Source: Bloomberg Finance L.P., ChinaAMC, iFAST Compilations. Data as of 30 September 2026.

The pullback does not necessarily make the theme cheap. While a comparable valuation series for the CSI Robot Index is not available, the FactSet China Robotics and AI Index offers a broad indication. As of 4 November 2026, it traded at about 41x forward and 75x trailing earnings, compared with about 14x and 16x for the CSI 300 Index.

The two robotics indices differ in their constituents, so the comparison is approximate. Even so, it suggests that investors are paying a substantial premium for robotics exposure. Any disappointment on humanoid orders or margins could weigh on both earnings estimates and valuation multiples.

How it compares with other ways to access the theme

The iFAST ChinaAMC CSI Robot Index ETF (SGX: RBZ) offers more focused A-share robotics exposure than the broader China technology and growth ETFs already on SGX, such as those tracking ChiNext or the CSI STAR and ChiNext 50. Outside SGX, investors can access China robotics through ETFs listed in China, Hong Kong and the US, though some of these follow different indices.

Cost is an important consideration. The ETF’s expected overall total expense ratio of 0.64% p.a. is broadly in line with the headline figures in Table 4, which range from 0.60% to 0.89%. As a feeder fund, the ETF also bears costs at both the iFAST and underlying fund levels. However, these ETFs track different indices, so investors should also compare what they hold, along with trading spreads and currency costs.

Table 4: Selected China robotics ETFs

ETF Name

iFAST ChinaAMC CSI Robot Index ETF (SGX: RBZ)

E Fund CNI Robot Industry Index ETF (SZSE: 159530)

Global X China Robotics and AI ETF (HKEX: 2807)

Defiance China Robotics ETF (NASDAQ: CROB)

Benchmark

CSI Robot Index

CNI Robot Industry Index

FactSet China Robotics and AI Index

Solactive China Humanoid Robotics Index

Trading Currency

SGD

CNY

HKD, USD

USD

Inception

Listing 7 Dec 2026

10 Jan 2024

7 Aug 2020

18 Aug 2026

AUM (mil)

-

CNY 18,413

HKD 668.16

USD 2.28

Total Expense Ratio

0.64% p.a. (expected)

0.60% p.a.

0.68% p.a.

0.89% p.a.

Avg. daily volume over the past 90D (‘000 shares)

-

707,800

95.2

5.2

Source: Bloomberg Finance L.P., iFAST Compilations. Data as of 5 Nov 2026.

There are already several passive ETFs tracking the CSI Robot Index in China, which investors can access through our platform. These funds are traded in CNY on the Shanghai and Shenzhen exchanges. The iFAST ChinaAMC CSI Robot Index ETF (SGX: RBZ) differs mainly in access, with SGD trading on SGX and SRS eligibility after its listing, rather than in its underlying exposure.

The ChinaAMC CSI Robot ETF (SSE: 562500), which the iFAST ChinaAMC CSI Robot Index ETF (SGX: RBZ) invests in, is the largest ETF tracking the CSI Robot Index, with AUM of about CNY 17.4 billion. Investors comfortable with trading in CNY may prefer to compare these existing funds on cost and liquidity, while those who value SGD trading or plan to use SRS funds may find the SGX listing more convenient.

Table 5: Passive ETFs tracking the CSI Robot Index

ETF

Inception

AUM (CNY m)

Expense ratio (p.a.)

Avg. daily volume over the past 90D (m shares)

iFAST ChinaAMC CSI Robot Index ETF (SGX: RBZ)

Listing 7 Dec 2026

-

0.64% (expected)

-

ChinaAMC CSI Robot ETF (SSE: 562500)

17 Dec 2021

17,444

0.60%

675.1

Tianhong CSI Robot ETF (SZSE: 159770)

26 Oct 2021

6,263

0.60%

156.3

China Merchants CSI Robot ETF (SSE: 560770)

21 Aug 2025

1,599

0.60%

28.8

China Southern CSI Robot ETF (SZSE: 159258)

24 Jul 2025

1,495

0.60%

32.4

Harvest CSI Robot ETF (SZSE: 159526)

16 Apr 2024

893

0.60%

20.6

China Universal CSI Robot ETF (SZSE: 159213)

21 Apr 2025

562

0.60%

31.5

Guotai CSI Robot ETF (SZSE: 159551)

8 Nov 2023

367

0.60%

17.7

Source: Bloomberg Finance L.P., iFAST Compilations. Data as of 5 Nov 2026.

Is the SGX-listed robot ETF right for you?

For investors seeking exposure to China’s robotics sector, the upcoming iFAST ChinaAMC CSI Robot Index ETF (SGX: RBZ) offers practical advantages in accessibility:

  • Trade conveniently in SGD without having to manually convert currencies when entering or exiting positions
  • Its one-share board lot and SGD 1 initial issue price make it easier to start small or invest regularly
  • Singapore and mainland China share the same time zone, so trading hours largely overlap with those of the underlying market, though prices may deviate from NAV when Shanghai is closed
  • The ETF will be SRS-eligible after listing, although the theme's volatility means it may not suit every retirement portfolio

Convenience does not remove the risks. Three stand out for this ETF:

  • Sentiment and valuation: Returns are closely tied to the humanoid theme, which can turn quickly. The index fell more than 7% intraday on 19 August 2026 as the World Robot Conference opened, and valuations leave little room for disappointment.
  • Price competition: Price wars among humanoid makers could put pressure on what component suppliers, which make up much of the index, can charge, even if robot volumes grow.
  • Policy dependence: Industrial policy has supported the sector, but regulators have also warned of bubble risk, so a change in policy tone could weigh on sentiment.

Investors should also note that the ETF is not hedged against movements in the CNY against the SGD.

The ETF may suit investors who want thematic exposure to automation. Given its concentration and volatility, we believe it is better suited as a small satellite position than a core holding, and investors already holding China technology funds should check for overlap.

China's robotics industry has genuine scale, but the humanoid opportunity remains unproven. For investors who want exposure to the theme, the new SGX listing makes access easier, but position sizing should allow for sharp drawdowns.

Declaration:

For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) and the analyst who produced this report hold a NIL position in the abovementioned securities.

This research report was prepared with the assistance of artificial intelligence (AI) tools. iFAST Financial Pte Ltd does not rely exclusively on AI for content generation; the content of this report, including all investment theses, ratings, price targets and conclusions, has been independently reviewed and verified by the research analyst(s) to ensure accuracy and professional integrity.


All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://fsm.global/sg/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.